Delivery Order SPE2DB20D2014-SPE2DB25FC89S
- Not listed
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract. The award, valued at $4,604.72, represents a non-set-aside competitive award with an ultimate completion date of June 10, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,019.92 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract. The award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract valued at $3,059.76. The order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) valued at $7,699.78 with a firm fixed price contract type. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 8, 2025, with a ceiling value of $20,275.18. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and no set-aside designation was applied. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,865.37 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-unit quantity), with performance in Conshohocken, Pennsylvania and completion by September 2, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. MULTAQ is an antiarrhythmic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and serves the federal government's pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,247.47. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which supplies pharmaceutical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC89SDelivery Order
The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's $1 billion DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle, enabling supply of a diverse range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for MULTAQ—a pharmaceutical used in cardiac care management—exemplifies the company's role as a key supplier within the Defense Health Agency supply chain and reflects DLA's continued reliance on AmerisourceBergen's capabilities to fulfill federal medical supply requirements through competitive procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/3/25 |